Meltzer HY - Search Results

1

Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia.

Lee MA, Cola P, Jayathilake K, Meltzer HY. Lee MA, et al. Among authors: meltzer hy. J Clin Psychopharmacol. 2023 May-Jun 01;43(3):211-219. doi: 10.1097/JCP.0000000000001671. Epub 2023 Mar 28. J Clin Psychopharmacol. 2023. PMID: 36975722

2

Reply to Dr Yucel's Comments on the Article "Long-term Outcome of Clozapine in Treatment-Resistant Schizophrenia".

Lee MA, Cola P, Jayathilake K, Meltzer HY. Lee MA, et al. Among authors: meltzer hy. J Clin Psychopharmacol. 2023 Nov-Dec 01;43(6):555-556. doi: 10.1097/JCP.0000000000001774. J Clin Psychopharmacol. 2023. PMID: 37930220 No abstract available.

3

Clozapine in treatment of bromocriptine-induced psychosis.

Al-Semaan YM, Clay HA, Meltzer HY. Al-Semaan YM, et al. Among authors: meltzer hy. J Clin Psychopharmacol. 1997 Apr;17(2):126-8. doi: 10.1097/00004714-199704000-00016. J Clin Psychopharmacol. 1997. PMID: 10950481 No abstract available.

4

A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study.

Arato M, O'Connor R, Meltzer HY; ZEUS Study Group. Arato M, et al. Among authors: meltzer hy. Int Clin Psychopharmacol. 2002 Sep;17(5):207-15. doi: 10.1097/00004850-200209000-00001. Int Clin Psychopharmacol. 2002. PMID: 12177583 Clinical Trial.

5

Mechanisms of clozapine-induced agranulocytosis.

Gerson SL, Meltzer H. Gerson SL, et al. Drug Saf. 1992;7 Suppl 1:17-25. doi: 10.2165/00002018-199200071-00007. Drug Saf. 1992. PMID: 1503673 Review.

6

Clozapine in treatment-resistant schizophrenics.

Kane JM, Honigfeld G, Singer J, Meltzer H. Kane JM, et al. Psychopharmacol Bull. 1988;24(1):62-7. Psychopharmacol Bull. 1988. PMID: 3290950 Clinical Trial. No abstract available.

7

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Kane J, Honigfeld G, Singer J, Meltzer H. Kane J, et al. Arch Gen Psychiatry. 1988 Sep;45(9):789-96. doi: 10.1001/archpsyc.1988.01800330013001. Arch Gen Psychiatry. 1988. PMID: 3046553 Clinical Trial.

8

Long-term effects of neuroleptic drugs on the neuroendocrine system.

Meltzer HY. Meltzer HY. Adv Biochem Psychopharmacol. 1985;40:59-68. Adv Biochem Psychopharmacol. 1985. PMID: 2862768 Review. No abstract available.

9

Lack of Efficacy of JNJ-18038683 on Cognitive Impairment in Patients With Stable Bipolar Disorder.

Arshadi M, Elmaadawi AZ, Nasr S, Jayathilake K, Rassnick S, Ford L, Drevets WC, Meltzer HY. Arshadi M, et al. Among authors: meltzer hy. J Clin Psychopharmacol. 2024 Sep-Oct 01;44(5):481-491. doi: 10.1097/JCP.0000000000001889. J Clin Psychopharmacol. 2024. PMID: 39250138 Clinical Trial.

10

Analysis of schizophrenia-associated genetic markers in the HLA region as risk factors for tardive dyskinesia.

Wang R, Lu JY, Herbert D, Lieberman JA, Meltzer HY, Tiwari AK, Remington G, Kennedy JL, Zai CC. Wang R, et al. Among authors: meltzer hy. Hum Psychopharmacol. 2024 Jul;39(4):e2898. doi: 10.1002/hup.2898. Epub 2024 Apr 27. Hum Psychopharmacol. 2024. PMID: 38676936

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

960 results

Search Page

Filters